GOSS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Gossamer Bio (GOSS) Earnings Date & Reports

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

GOSS is expected to report earnings to rise 26.67% to -18 cents per share on May 13

Gossamer Bio GOSS Stock Earnings Reports

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.02

Q3'24

Beat

by $0.01

Q2'24

Missed

by $0.29

Q1'24

Est.

$-0.19

The last earnings report on March 13 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 1.27M shares outstanding, the current market capitalization sits at 214.09M.

View a ticker or compare two or three

Compare

GOSS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GOSS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

3013 Science Park Road

Phone

+1 858 684-1300

Employees

135

Web

https://www.gossamerbio.com